Researchers from Moffitt Cancer Centre have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with...
Vous n'êtes pas connecté
Researchers from Moffitt Cancer Centre have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published in the Journal for ImmunoTherapy of Cancer, shows that blocking MARCO in combination with a type of immunotherapy known as anti-CTLA4 therapy significantly enhances tumour regression in melanoma, the deadliest [...]
Researchers from Moffitt Cancer Centre have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with...
Suppressing the ZNF638 protein tricks the body into attacking glioblastoma , a potential breakthrough in brain cancer therapy.
Suppressing the ZNF638 protein tricks the body into attacking glioblastoma , a potential breakthrough in brain cancer therapy.
A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the Department of Surgery at the...
Antibody treatment which activates the patient’s immune system against cancer, known as immunotherapy, is increasingly being investigated as an...
Antibody treatment which activates the patient’s immune system against cancer, known as immunotherapy, is increasingly being investigated as an...
A new study led by UCLA investigators suggests that chronic stress and an unhealthy diet may work together to fuel the early development of pancreatic...
A new study led by UCLA investigators suggests that chronic stress and an unhealthy diet may work together to fuel the early development of pancreatic...
Breast cancer is one of the leading causes of mortality among women worldwide. Tumour necrosis factor α-induced protein 3-interacting protein 1...
Breast cancer is one of the leading causes of mortality among women worldwide. Tumour necrosis factor α-induced protein 3-interacting protein 1...